PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Vaccine produces long-lasting anti-tumor response in patients with melanoma

2021-01-21
(Press-News.org) BOSTON - Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Broad Institute of MIT and Harvard report in a new study.

The findings, published online today by the journal Nature Medicine, demonstrate the staying power of the immune response generated by the vaccine, known as NeoVax, which works by targeting specific proteins on each patient's tumor cells. The researchers found that, nearly four years after vaccination, the patients' immune system cells were active not only against tumor cells with those distinctive proteins, but also spread to other proteins found in those patients' tumor cells.

"These findings demonstrate that a personal neoantigen vaccine can stimulate a durable immune response in patients with melanoma," says study co-leader Catherine J. Wu, MD, of Dana-Farber, Brigham and Women's Hospital (BWH), and the Broad Institute. "We found evidence that the initial, targeted immune response has broadened over the years to provide patients with continued protection from the disease."

The study involved eight patients who had undergone surgery for advanced melanoma but were considered at high risk of recurrence. In a Phase 1 clinical trial, they were treated with NeoVax a median of 18 weeks after surgery. The vaccine is made from bits of proteins, called epitopes, that poke from the cell surface and serve as signals to the immune system. The epitopes in NeoVax come from neoantigens - abnormal proteins on tumor cells that warn that a cell is cancerous and should be destroyed. Because neoantigens are found only on tumor cells, they trigger an immune response that spares normal cells from attack.

To make NeoVax, the sequence of DNA in a patient's tumor is scanned in order to identify the key epitopes within the tumor cell neoantigens. The epitopes serve as targets for T cells, which lead the immune system's attack on cancer. When a patient is treated with NeoVax, the epitopes draw an immune system response against any melanoma cell that displays them.

In the new study, researchers found that a median of four years after NeoVax treatment, all eight patients were alive, with six showing no signs of active disease. When they analyzed the patients' T cells - the immune system cells spurred to action by the vaccine - they found evidence that the cells not only "remembered" their initial target epitopes but had expanded their repertoire to recognize other melanoma-related epitopes as well.

Two of the patients, whose cancer had spread to their lungs, also received an immune checkpoint inhibitor, a drug that loosens some of the restraints on the immune response to cancer. In those two patients, the researchers detected signs that T cells had made their way into the tumor tissue, where they could be most lethal to melanoma cells.

"We found evidence of everything we look for in a strong, sustained immune response," says Patrick A. Ott, MD, PhD, of Dana-Farber, Brigham and Women's Hospital (BWH), and the Broad Institute, who co-led the study with Wu. "T cells continued to specifically target melanoma cells and retained a memory of the epitopes they initially responded to. The T cells were activated to kill tumor cells and, critically, had diversified to target melanoma epitopes not included in the original vaccine.

"The long-term persistence and expansion of the melanoma-targeting T cells is a strong indication that personal neoantigen peptide vaccines can help control metastatic tumors, particularly when combined with immune checkpoint inhibition."

INFORMATION:

The lead authors of the study are Zhuting Hu, PhD, and Donna E. Leet, of Dana-Farber. The co-authors are Rosa L. Allesoe, of the University of Copenhagen; Giacomo Oliveira, PhD, Adrienne M. Luoma, PhD, Teddy Huang, PhD, Robert Redd, MS, Jing Sun, PhD, Anita Giobbie-Hurder, MS, Wandi Zhang, Zoe Ciantra, Oriol Olive, Keerthi Shetty, PhD, MBA, Jason Pyrdol, Mohamed Uduman, PhD, Patrick C. Lee, Donna Neuberg, ScD, Kenneth J. Livak, PhD, and Kai Wucherpfennig, MD, PhD, of Dana-Farber; Shuqiang Li, PhD, Juliet Forman, Sachet A. Shukla, PhD, Edward F. Fritsch, PhD, and Derin B. Keskin, PhD, of Dana-Farber and the Broad Institute; Pavan Bachireddy, MD, of Dana-Farber, the Broad Institute, and BWH; Satyen Gohil, MD, PhD, of Dana-Farber, the Broad Institute and University College, London; J. Bryan Iorgulescu, MD, Elizabeth I. Buchbinder, MD, and Scott Rodig, MD, PhD, of Dana-Farber and BWH; Jinyan Liu, MD, PhD, and Lauren Peter, of Beth Israel Deaconess Medical Center; Rebecca Holden, PhD, of Massachusetts Institute of Technology (MIT); Bradley L. Pentelute, PhD, of MIT and the Broad Institute; Siranush Sarkizova, PhD, and Liudmilla Elagina, of the Broad Institute; Nir Hacohen, PhD, of the Broad Institute and Massachusetts General Hospital; Charles H. Yoon, MD, PhD, of BWH; Lars Rønn Olsen, of Technical University of Denmark and Copenhagen University Hospital; and Dan H. Barouch, MD, PhD, of Beth Israel Deaconess Medical Center and the Ragon Institute of MGH, MIT, and Harvard.

Financial support for the study was provided by the Blavatnik Family Foundation, the National Institutes of Health (grants NCI-1R01CA155010; NCI- U24CA22433; NCI-SPORE-2P50CA101942-11A1; NCI-R50 RCA211482A; NCI-R50 CA251956; NCI-R01 CA229261; NCI P01 CA163222; NCI- R01 CA238039; and NCI-5T32HL007627); the Melanoma Research Alliance; the Francis and Adele Kittredge Family Immuno-Oncology and Melanoma Research Fund; the Faircloth Family Research Fund; the Bender Family Research Fund, a Dana-Farber Cancer Institute Cancer Immunotherapy Research fellowship and 5 T32 CA 207021-3; the Damon Runyon Cancer Research Foundation; the Be The Match Foundation; the American Society of Hematology; an NSF Graduate Research Fellowship; a Kay Kendall Leukaemia Fund Fellowship, the G. Harold and Leila Y. Mathers Foundation; and the Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center, the Howard Hughes Medical Institute Medical Research Fellows Program and the Novo Nordisk Foundation (grant agreement NNF14CC0001).

About Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is one of the world's leading centers of cancer research and treatment. Dana-Farber's mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. We provide the latest treatments in cancer for adults through Dana-Farber/Brigham and Women's Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 10 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.

As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.



ELSE PRESS RELEASES FROM THIS DATE:

Opiate overdoses spike in black Philadelphians, but drop in white residents since COVID-19

2021-01-21
While it has been reported that opioid overdose deaths have increased during the COVID-19 pandemic, a new study looking at data in Philadelphia showed that this hardship has been overwhelmingly suffered by Black individuals. Researchers from the Perelman School of Medicine at the University of Pennsylvania analyzed the period of time after the city's stay-at-home order was announced in 2020 and showed that, compared to the year before, the number of fatal overdoses suffered by Black individuals spiked by more than 50 percent. At the same time, the rate for white individuals actually fell by 31 percent over the same period. This research ...

Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients

Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients
2021-01-21
PORTLAND, OR - A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn't live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens, according to trial results published in JAMA Oncology. While the trial findings did not show a direct patient benefit, they do show that it's possible to safely administer chemotherapy prior to pancreatic cancer surgery. They also pave the way for better treatment testing for this notorious killer. With no symptoms in the early stages, and few effective therapies, pancreatic cancer is the fourth-most deadly cancer type in the United ...

Suicide-related internet searches during early stages of COVID-19 pandemic

2021-01-21
What The Study Did: This study monitored suicide-related internet search rates during the early stages of the COVID-19 pandemic in the United States and researchers report searches for suicide decreased during that time. Although this study cannot independently confirm that changes in search rates were caused by changes in population-level suicide rates, it showed that COVID-19 may have been inversely associated with population suicide trends between March and July 2020. Authors: John W. Ayers, Ph.D., M.A., of theUniversity of California San Diego, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.34261) Editor's ...

Presence of SARS-CoV-2 RNA in cornea of patients with COVID-19

2021-01-21
What The Study Did: Evidence of SARS-CoV-2 RNA in human corneas was examined in this study. Authors: Maria Casagrande, M.D., of the University Medical Center Hamburg-Eppendorf in Hamburg, Germany, is the corresponding author.  To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaophthalmol.2020.6339) Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: The full article is linked to this news release. Embed ...

Suicide deaths during COVID-19 stay-at-home advisory in Massachusetts

2021-01-21
What The Study Did: Researchers assembled suicide death data for people 10 and older from January 2015 through May 2020 in this observational study and they report stable rates of suicide deaths during the COVID-19 stay-at-home advisory in Massachusetts, a finding that paralleles others following ecological disasters. Authors: Jeremy Samuel Faust, M.D., M.S., of Brigham and Women's Hospital and Harvard Medical School in Boston, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.34273) Editor's ...

Reports of forgone medical care among US adults during initial phase of COVID-19 pandemic

2021-01-21
What The Study Did: This study estimated the frequency of reported forgone medical care because of the COVID-19 pandemic from March to mid-July 2020, including missed doses of prescription medications, forgone preventive and other general medical care, mental health care and elective surgeries, as well as reasons for forgoing care. Authors: Kelly E. Anderson, M.P.P., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.34882) Editor's Note: The article includes conflict of interest and funding/support ...

Racial/ethnic disparities in unintentional EMS-attended opioid overdoses during COVID-19 pandemic

2021-01-21
What The Study Did: Associations of the COVID-19 pandemic with overdoses among racial/ethnic groups in Philadelphia are described in this observational study. Authors: Utsha G. Khatri, M.D., of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.34878) Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: The full ...

Pediatric eye injuries, hand sanitizers during COVID-19 pandemic

2021-01-21
What The Study Did: An increase in pediatric cases of alcohol-based hand sanitizer eye exposure was assessed in this study, which also described the severity of ocular lesions and their management. Authors: Gilles C. Martin, M.D., M.Sc., of theRothschild Foundation Hospital in Paris, is the corresponding author. To access the embargoed study:  Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaophthalmol.2020.6346) Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

Hand sanitizer-induced ocular injury

2021-01-21
What The Study Did: The cases of two children with eye injuries after unintentional contact between alcohol-based hand rubs and the eye are described in this observation. Authors: Sonam Yangzes, M.S., of the Grewal Eye Institute in Chandigarh, India, is the corresponding author.  To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaophthalmol.2020.6351) Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media ...

Safe, efficient performance of open tracheostomies in patients with COVID-19

2021-01-21
What The Study Did: Researchers demonstrate a technique of tracheostomy that minimizes aerosolization risks while creating a tight seal around the tracheostomy tube. Authors: Oluwafunmilola T. Okuyemi, M.D., M.S.C.I., of the University of Nevada, Las Vegas School of Medicine, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  (doi:10.1001/jamaoto.2020.4432) Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, ...

LAST 30 PRESS RELEASES:

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

[Press-News.org] Vaccine produces long-lasting anti-tumor response in patients with melanoma